TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS. JIMKI 2022, 9 (3), 92-101. https://doi.org/10.53366/jimki.v9i3.488.